data_6img_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6img _Structure_validation_residue.Date_analyzed 2019-08-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.4 t -62.53 129.06 92.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.453 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.27 -23.04 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.908 2.405 . . . . 0.0 112.203 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.36 129.85 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 6' ' ' ILE . 95.5 mt -62.21 -44.75 99.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -110.56 112.44 56.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.54 -23.07 32.2 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.885 2.39 . . . . 0.0 111.485 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -72.2 -19.67 61.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.119 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.48 -5.46 25.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.625 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -127.98 67.93 74.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.367 0.604 . . . . 0.0 110.666 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.73 -20.22 35.28 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.86 2.373 . . . . 0.0 112.782 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -81.45 3.54 24.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mm -108.05 114.55 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -60.51 -32.72 71.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.6 m -63.35 -37.23 86.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.553 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.543 -179.603 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.73 129.82 91.79 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.24 -24.74 50.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.115 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.54 129.36 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.079 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.2 -45.04 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.58 110.4 62.78 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.95 -23.24 41.01 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.574 2.183 . . . . 0.0 112.632 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -72.3 -19.51 61.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.35 -3.36 27.24 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.8 m -129.51 68.02 79.76 Favored Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 120.985 0.422 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.07 -19.6 34.42 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.123 2.549 . . . . 0.0 112.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -81.09 2.9 25.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.13 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -108.16 114.43 46.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -59.53 -32.87 70.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.774 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 m -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.656 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.579 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.9 129.55 94.48 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.62 -22.07 33.26 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.455 2.103 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 m -81.32 129.59 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.73 -44.93 99.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.764 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.14 111.45 60.25 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.89 -22.15 42.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.148 1.898 . . . . 0.0 112.161 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -71.83 -18.61 62.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -101.09 -5.52 25.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.857 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -129.57 68.35 80.3 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 121.166 0.507 . . . . 0.0 110.571 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.28 -18.51 39.23 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.229 2.619 . . . . 0.0 112.136 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -84.46 4.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.353 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mm -110.82 115.01 48.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -60.12 -32.13 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.035 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.2 m -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.301 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.622 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.3 129.65 91.03 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.583 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 -21.8 44.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 m -85.73 128.91 34.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 6' ' ' ILE . 96.7 mt -62.88 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.133 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -108.13 108.92 61.72 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.026 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 -20.49 54.06 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.853 2.369 . . . . 0.0 112.691 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -74.46 -16.31 60.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.614 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.87 -4.97 22.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.635 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.55 67.72 76.85 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-O 121.23 0.538 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.83 -19.33 35.94 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.926 2.417 . . . . 0.0 112.47 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -81.95 5.8 17.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 mm -110.28 121.79 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-O 120.809 0.338 . . . . 0.0 110.099 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -65.87 -32.22 73.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.683 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.5 m -64.65 -39.73 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.519 -179.786 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.381 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.5 t -61.81 129.6 91.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.601 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.39 -26.17 41.34 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.258 1.972 . . . . 0.0 112.371 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.5 m -78.62 129.47 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -44.41 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.031 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -107.53 111.11 63.0 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.31 -22.53 39.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.808 1.672 . . . . 0.0 111.731 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.42 -21.76 61.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.301 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.98 -15.82 20.91 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.0 m -121.34 66.4 16.99 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.89 -18.23 36.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.415 2.743 . . . . 0.0 111.894 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -82.46 4.42 24.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.22 117.95 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -58.73 -32.77 69.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.817 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.8 m -65.27 -38.13 89.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.813 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.5 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.88 128.62 93.95 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.035 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.79 -19.76 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.69 127.87 34.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.15 -45.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.178 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -107.12 109.26 62.89 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.94 -21.46 49.94 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.272 1.981 . . . . 0.0 112.308 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -72.72 -19.04 61.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.47 -4.59 26.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.119 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.9 m -129.09 67.04 77.82 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 110.535 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 -18.0 38.27 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.849 2.366 . . . . 0.0 111.467 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -81.54 7.16 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.006 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.73 122.48 67.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -65.32 -32.97 74.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.53 -40.03 94.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.29 129.58 92.43 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.698 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.09 -21.22 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.638 2.226 . . . . 0.0 112.62 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.92 129.67 34.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.03 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.329 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -107.97 110.15 62.2 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.739 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.74 -24.05 47.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.818 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -71.76 -18.4 62.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.41 -5.66 25.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.808 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -128.58 67.82 77.15 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 121.175 0.512 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.14 -19.02 34.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.131 2.554 . . . . 0.0 112.102 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -80.69 3.17 23.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.7 mm -108.23 120.18 59.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -63.73 -31.77 73.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.549 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -65.36 -40.09 93.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.725 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.388 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.7 t -62.72 129.37 92.89 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.513 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.25 -20.4 32.58 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.0 1.8 . . . . 0.0 112.416 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.89 129.3 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.305 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -108.11 110.0 62.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.284 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.27 -22.84 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.94 1.76 . . . . 0.0 112.909 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.56 -21.12 61.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.575 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.4 mt -100.0 -2.18 35.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.101 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m -129.07 67.43 78.38 Favored Pre-proline 0 C--O 1.231 0.112 0 CA-C-O 121.224 0.535 . . . . 0.0 110.583 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.95 -21.94 36.58 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.198 2.599 . . . . 0.0 111.777 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -78.16 0.99 22.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.561 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.5 mm -107.56 119.98 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.24 -32.03 73.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.9 t -63.83 -43.41 96.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.5 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -53.81 129.68 56.04 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.972 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.24 -23.07 33.59 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.276 1.984 . . . . 0.0 112.599 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.13 128.55 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.67 -45.4 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -107.88 108.03 60.95 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.904 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.3 -22.15 53.47 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.275 1.983 . . . . 0.0 112.884 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.8 -19.8 61.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.428 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -100.15 -3.37 31.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -129.61 67.95 79.8 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 121.095 0.474 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.18 -20.42 37.61 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 123.234 2.623 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -80.48 2.01 27.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 mm -108.6 114.56 47.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.74 -31.82 69.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.896 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -64.4 -38.11 89.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.485 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.509 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.9 t -62.51 129.55 92.71 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.976 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -20.33 34.38 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.418 2.079 . . . . 0.0 112.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.4 126.89 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -45.13 99.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -106.3 108.91 62.64 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.935 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.37 -22.46 45.68 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.423 2.082 . . . . 0.0 112.568 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.24 -20.49 61.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.777 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.7 -5.34 28.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.144 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -128.19 67.45 74.89 Favored Pre-proline 0 C--N 1.333 -0.131 0 CA-C-O 121.315 0.578 . . . . 0.0 110.257 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.64 -18.99 37.26 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 123.514 2.809 . . . . 0.0 112.05 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -82.3 4.26 24.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.294 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.3 mm -109.11 120.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.876 0.37 . . . . 0.0 110.022 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -64.1 -32.49 74.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.89 -39.61 93.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 -179.688 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.94 129.49 93.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.807 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.22 -21.66 31.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.897 1.731 . . . . 0.0 112.396 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.43 129.21 34.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.41 -45.2 99.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.252 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -107.5 109.9 62.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.243 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.96 -22.49 41.98 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.932 1.754 . . . . 0.0 112.514 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.11 -20.75 62.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.564 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.9 mt -99.53 -4.64 30.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.999 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.33 67.26 78.47 Favored Pre-proline 0 C--O 1.232 0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.495 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.35 -21.96 34.63 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 123.19 2.593 . . . . 0.0 111.928 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -78.65 1.88 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.522 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mm -107.07 121.61 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -64.12 -32.65 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.3 m -64.96 -40.0 94.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.629 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.29 129.78 94.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.844 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.53 -22.67 28.22 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.013 1.809 . . . . 0.0 111.968 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 m -81.03 127.27 32.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.309 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.83 -45.07 99.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.913 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -106.91 110.76 63.79 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.83 -20.61 39.24 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.024 1.816 . . . . 0.0 112.48 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -72.39 -19.27 61.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.631 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.25 -4.01 27.92 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.175 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -129.42 67.37 78.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.145 0.498 . . . . 0.0 110.643 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.43 -20.31 36.53 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.129 2.553 . . . . 0.0 112.039 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -80.57 3.65 21.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.318 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.88 121.63 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -64.89 -31.89 73.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.966 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.49 -39.86 92.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.458 -179.822 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.528 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.7 t -64.64 129.28 94.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.636 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 -24.7 27.07 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.14 1.894 . . . . 0.0 112.112 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.38 128.42 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.66 -45.56 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.43 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -108.28 110.1 61.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 -22.63 47.18 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.14 1.893 . . . . 0.0 112.553 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.51 -20.02 61.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.26 -3.54 31.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.022 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -129.49 68.59 80.55 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.033 0.444 . . . . 0.0 110.669 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 -22.04 38.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.122 2.548 . . . . 0.0 112.119 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -79.29 3.13 18.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 mm -109.59 114.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.6 -31.41 70.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.66 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -64.38 -37.74 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.454 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.573 -179.63 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.68 129.64 91.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.711 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.83 -21.4 33.24 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.017 1.811 . . . . 0.0 112.542 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -82.88 129.44 35.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.59 -45.23 99.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.139 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -107.72 110.23 62.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.27 -21.82 47.29 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.905 1.736 . . . . 0.0 112.524 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.33 -20.62 61.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.341 . . . . 0.0 110.743 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.87 -3.77 31.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.199 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 88.3 m -129.48 67.34 78.78 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 121.226 0.536 . . . . 0.0 110.517 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.56 -20.96 35.1 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.313 2.675 . . . . 0.0 111.754 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -78.73 1.69 22.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.197 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.5 120.95 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.52 -32.48 74.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.57 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.6 t -64.04 -43.52 95.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.481 -179.805 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.332 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.85 129.64 90.25 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.569 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.79 -22.41 36.9 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.618 2.212 . . . . 0.0 112.398 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.6 129.06 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -45.41 98.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.068 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -107.82 112.09 62.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.099 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 -22.03 38.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.439 2.093 . . . . 0.0 112.557 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -72.78 -17.86 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.638 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.58 -6.25 23.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.684 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.6 m -128.24 68.02 76.05 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-O 121.095 0.474 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -19.77 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.285 2.656 . . . . 0.0 112.074 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -79.57 2.64 21.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.883 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -108.91 112.99 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -57.97 -32.86 68.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.768 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.974 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.726 -179.442 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -64.41 130.25 94.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.911 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.01 -22.52 26.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.837 1.691 . . . . 0.0 112.355 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -78.08 128.44 33.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.391 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.85 -45.35 99.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.24 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -107.16 108.22 61.6 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.39 -21.83 46.51 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.837 1.692 . . . . 0.0 112.516 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.53 -21.28 62.75 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.2 mt -99.07 -2.99 35.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.7 m -129.67 68.3 80.34 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 121.363 0.601 . . . . 0.0 110.581 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.76 -22.28 32.31 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.003 2.469 . . . . 0.0 111.881 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -78.49 -0.29 28.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.599 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -105.36 121.14 57.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.04 -32.52 74.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.031 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.517 -179.791 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -62.23 129.73 92.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.028 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.1 -23.92 60.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.14 1.893 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 m -84.5 128.26 34.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.328 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.33 -44.54 99.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.984 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -106.79 108.83 62.58 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.024 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.57 -21.77 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.021 1.814 . . . . 0.0 112.926 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -18.56 62.96 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.692 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.25 -5.14 25.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.331 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.28 67.3 78.45 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.239 0.542 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.47 -21.31 40.55 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.24 2.627 . . . . 0.0 112.309 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -80.58 3.71 20.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.58 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.1 mm -108.76 120.8 60.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.979 0.419 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -63.15 -31.72 72.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.09 -39.69 93.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.78 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.596 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.86 129.51 93.2 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.784 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.86 -22.12 43.13 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.048 1.832 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.31 129.07 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.17 -45.26 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.06 109.28 61.93 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.87 -23.53 47.48 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.023 1.815 . . . . 0.0 112.506 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -70.35 -20.97 62.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.402 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.92 -6.1 29.5 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.8 m -129.05 67.28 78.13 Favored Pre-proline 0 C--N 1.335 -0.032 0 CA-C-O 121.351 0.596 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -20.88 33.68 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.17 2.58 . . . . 0.0 111.825 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -79.19 0.31 28.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.296 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -105.36 113.85 43.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -57.38 -32.28 66.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.2 t -64.87 -40.23 94.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -179.427 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.3 t -62.86 129.42 93.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.859 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -20.87 33.95 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.284 1.99 . . . . 0.0 112.411 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.0 m -82.67 128.21 34.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.241 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.21 -45.4 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.914 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.97 109.9 62.14 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.937 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.54 -21.98 52.01 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.211 1.941 . . . . 0.0 112.788 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -71.1 -19.48 62.45 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.416 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.15 -4.77 28.96 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.5 m -129.23 66.95 77.83 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 121.177 0.513 . . . . 0.0 110.331 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.2 -20.53 37.33 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.317 2.678 . . . . 0.0 111.874 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -81.65 5.75 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mm -110.62 121.09 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -63.57 -32.21 73.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.576 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.4 m -64.59 -39.95 94.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.466 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t -65.51 129.73 94.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.906 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.37 -20.3 21.15 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.987 2.458 . . . . 0.0 112.263 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 131.61 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.8 -43.95 98.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.37 . . . . 0.0 110.472 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -109.64 112.17 58.75 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.195 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.99 -22.17 31.39 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.606 2.204 . . . . 0.0 111.838 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.33 -22.14 60.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.751 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.71 -14.93 21.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.1 m -123.3 65.2 29.69 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 121.419 0.628 . . . . 0.0 110.214 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -15.26 33.43 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.366 2.711 . . . . 0.0 112.671 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -85.13 4.01 36.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.808 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -106.56 116.09 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -58.84 -32.12 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.76 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 m -66.51 -38.51 87.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.617 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 -179.476 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.59 178.01 53.96 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.4 t -62.53 129.06 92.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.453 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.27 -23.04 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.908 2.405 . . . . 0.0 112.203 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.36 129.85 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 6' ' ' ILE . 95.5 mt -62.21 -44.75 99.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -110.56 112.44 56.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.54 -23.07 32.2 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.885 2.39 . . . . 0.0 111.485 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -72.2 -19.67 61.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.119 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.48 -5.46 25.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.625 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -127.98 67.93 74.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.367 0.604 . . . . 0.0 110.666 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.73 -20.22 35.28 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.86 2.373 . . . . 0.0 112.782 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -81.45 3.54 24.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mm -108.05 114.55 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -60.51 -32.72 71.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.6 m -63.35 -37.23 86.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.553 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.71 -17.88 39.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.543 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 120.092 -1.63 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.69 174.78 42.1 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.73 129.82 91.79 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.24 -24.74 50.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.115 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.54 129.36 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.079 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.2 -45.04 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.58 110.4 62.78 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.95 -23.24 41.01 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.574 2.183 . . . . 0.0 112.632 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -72.3 -19.51 61.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.35 -3.36 27.24 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.8 m -129.51 68.02 79.76 Favored Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 120.985 0.422 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.07 -19.6 34.42 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.123 2.549 . . . . 0.0 112.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -81.09 2.9 25.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.13 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 33.1 mm -108.16 114.43 46.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -59.53 -32.87 70.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.774 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 m -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.656 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.9 m -82.28 -26.01 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.579 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 O-C-N 120.041 -1.662 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.68 166.63 36.8 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.9 129.55 94.48 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.62 -22.07 33.26 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.455 2.103 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 m -81.32 129.59 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.73 -44.93 99.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.764 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.14 111.45 60.25 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.89 -22.15 42.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.148 1.898 . . . . 0.0 112.161 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -71.83 -18.61 62.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -101.09 -5.52 25.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.857 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -129.57 68.35 80.3 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 121.166 0.507 . . . . 0.0 110.571 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.28 -18.51 39.23 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.229 2.619 . . . . 0.0 112.136 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -84.46 4.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.353 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mm -110.82 115.01 48.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -60.12 -32.13 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.035 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.2 m -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.301 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.94 -7.26 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.622 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 O-C-N 119.956 -1.715 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.64 -173.88 53.99 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.3 129.65 91.03 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.583 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 -21.8 44.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 m -85.73 128.91 34.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 6' ' ' ILE . 96.7 mt -62.88 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.133 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -108.13 108.92 61.72 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.026 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 -20.49 54.06 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.853 2.369 . . . . 0.0 112.691 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -74.46 -16.31 60.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.614 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.87 -4.97 22.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.635 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.55 67.72 76.85 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-O 121.23 0.538 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.83 -19.33 35.94 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.926 2.417 . . . . 0.0 112.47 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -81.95 5.8 17.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 mm -110.28 121.79 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-O 120.809 0.338 . . . . 0.0 110.099 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -65.87 -32.22 73.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.683 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.5 m -64.65 -39.73 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 m -81.32 -22.25 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.519 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.33 0 O-C-N 120.055 -1.653 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.053 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.67 -171.46 52.73 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.5 t -61.81 129.6 91.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.601 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.39 -26.17 41.34 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.258 1.972 . . . . 0.0 112.371 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.5 m -78.62 129.47 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -44.41 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.031 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -107.53 111.11 63.0 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.31 -22.53 39.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.808 1.672 . . . . 0.0 111.731 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.42 -21.76 61.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.301 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.98 -15.82 20.91 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.0 m -121.34 66.4 16.99 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.89 -18.23 36.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.415 2.743 . . . . 0.0 111.894 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -82.46 4.42 24.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.0 mm -109.22 117.95 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -58.73 -32.77 69.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.817 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.8 m -65.27 -38.13 89.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.813 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -80.96 -17.25 51.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.5 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.357 0 O-C-N 120.082 -1.636 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.66 -177.54 53.42 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.88 128.62 93.95 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.035 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.79 -19.76 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.69 127.87 34.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.15 -45.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.178 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -107.12 109.26 62.89 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.94 -21.46 49.94 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.272 1.981 . . . . 0.0 112.308 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -72.72 -19.04 61.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.47 -4.59 26.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.119 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.9 m -129.09 67.04 77.82 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 110.535 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 -18.0 38.27 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.849 2.366 . . . . 0.0 111.467 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -81.54 7.16 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.006 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.73 122.48 67.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -65.32 -32.97 74.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.53 -40.03 94.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.76 -15.33 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 O-C-N 119.913 -1.742 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.29 -175.64 47.55 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.29 129.58 92.43 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.698 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.09 -21.22 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.638 2.226 . . . . 0.0 112.62 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.92 129.67 34.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.03 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.329 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -107.97 110.15 62.2 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.739 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.74 -24.05 47.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.818 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -71.76 -18.4 62.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.41 -5.66 25.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.808 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -128.58 67.82 77.15 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 121.175 0.512 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.14 -19.02 34.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.131 2.554 . . . . 0.0 112.102 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -80.69 3.17 23.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.7 mm -108.23 120.18 59.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -63.73 -31.77 73.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.549 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -65.36 -40.09 93.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.725 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m -81.1 -2.19 47.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.264 0 O-C-N 119.978 -1.701 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.047 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.16 150.4 16.84 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.7 t -62.72 129.37 92.89 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.513 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.25 -20.4 32.58 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.0 1.8 . . . . 0.0 112.416 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.89 129.3 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.305 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -108.11 110.0 62.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.284 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.27 -22.84 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.94 1.76 . . . . 0.0 112.909 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.56 -21.12 61.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.575 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.4 mt -100.0 -2.18 35.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.101 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m -129.07 67.43 78.38 Favored Pre-proline 0 C--O 1.231 0.112 0 CA-C-O 121.224 0.535 . . . . 0.0 110.583 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.95 -21.94 36.58 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.198 2.599 . . . . 0.0 111.777 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -78.16 0.99 22.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.561 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.5 mm -107.56 119.98 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.24 -32.03 73.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.9 t -63.83 -43.41 96.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.33 -31.64 58.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 O-C-N 120.042 -1.661 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.58 96.65 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -53.81 129.68 56.04 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.972 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.24 -23.07 33.59 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.276 1.984 . . . . 0.0 112.599 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.13 128.55 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.67 -45.4 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -107.88 108.03 60.95 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.904 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.3 -22.15 53.47 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.275 1.983 . . . . 0.0 112.884 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.8 -19.8 61.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.428 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -100.15 -3.37 31.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -129.61 67.95 79.8 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 121.095 0.474 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.18 -20.42 37.61 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 123.234 2.623 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -80.48 2.01 27.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 mm -108.6 114.56 47.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.74 -31.82 69.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.896 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -64.4 -38.11 89.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.485 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 m -82.87 -29.31 29.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.509 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.29 0 O-C-N 120.123 -1.61 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.77 48.57 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.9 t -62.51 129.55 92.71 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.976 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -20.33 34.38 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.418 2.079 . . . . 0.0 112.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.4 126.89 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -45.13 99.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -106.3 108.91 62.64 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.935 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.37 -22.46 45.68 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.423 2.082 . . . . 0.0 112.568 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.24 -20.49 61.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.777 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.7 -5.34 28.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.144 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -128.19 67.45 74.89 Favored Pre-proline 0 C--N 1.333 -0.131 0 CA-C-O 121.315 0.578 . . . . 0.0 110.257 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.64 -18.99 37.26 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 123.514 2.809 . . . . 0.0 112.05 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -82.3 4.26 24.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.294 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.3 mm -109.11 120.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.876 0.37 . . . . 0.0 110.022 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -64.1 -32.49 74.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.89 -39.61 93.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.37 -14.69 54.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.286 0 O-C-N 119.914 -1.741 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.11 158.99 53.82 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.94 129.49 93.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.807 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.22 -21.66 31.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.897 1.731 . . . . 0.0 112.396 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.43 129.21 34.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.41 -45.2 99.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.252 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -107.5 109.9 62.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.243 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.96 -22.49 41.98 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.932 1.754 . . . . 0.0 112.514 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.11 -20.75 62.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.564 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.9 mt -99.53 -4.64 30.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.999 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.33 67.26 78.47 Favored Pre-proline 0 C--O 1.232 0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.495 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.35 -21.96 34.63 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 123.19 2.593 . . . . 0.0 111.928 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -78.65 1.88 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.522 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mm -107.07 121.61 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -64.12 -32.65 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.3 m -64.96 -40.0 94.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -81.36 -3.3 52.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 O-C-N 119.983 -1.698 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.26 -179.05 48.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.29 129.78 94.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.844 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.53 -22.67 28.22 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.013 1.809 . . . . 0.0 111.968 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 m -81.03 127.27 32.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.309 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.83 -45.07 99.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.913 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -106.91 110.76 63.79 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.83 -20.61 39.24 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.024 1.816 . . . . 0.0 112.48 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -72.39 -19.27 61.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.631 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.25 -4.01 27.92 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.175 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -129.42 67.37 78.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.145 0.498 . . . . 0.0 110.643 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.43 -20.31 36.53 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.129 2.553 . . . . 0.0 112.039 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -80.57 3.65 21.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.318 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -108.88 121.63 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -64.89 -31.89 73.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.966 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.49 -39.86 92.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.26 -27.43 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 120.192 -1.567 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.91 172.2 46.19 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.7 t -64.64 129.28 94.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.636 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 -24.7 27.07 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.14 1.894 . . . . 0.0 112.112 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.38 128.42 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.66 -45.56 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.43 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -108.28 110.1 61.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 -22.63 47.18 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.14 1.893 . . . . 0.0 112.553 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.51 -20.02 61.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.26 -3.54 31.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.022 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -129.49 68.59 80.55 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.033 0.444 . . . . 0.0 110.669 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 -22.04 38.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.122 2.548 . . . . 0.0 112.119 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -79.29 3.13 18.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.5 mm -109.59 114.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.6 -31.41 70.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.66 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -64.38 -37.74 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.454 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.33 -11.82 53.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.573 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 O-C-N 120.026 -1.671 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.39 178.56 48.43 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.68 129.64 91.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.711 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.83 -21.4 33.24 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.017 1.811 . . . . 0.0 112.542 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -82.88 129.44 35.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.59 -45.23 99.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.139 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -107.72 110.23 62.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.27 -21.82 47.29 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.905 1.736 . . . . 0.0 112.524 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.33 -20.62 61.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.341 . . . . 0.0 110.743 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.87 -3.77 31.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.199 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 88.3 m -129.48 67.34 78.78 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 121.226 0.536 . . . . 0.0 110.517 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.56 -20.96 35.1 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.313 2.675 . . . . 0.0 111.754 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -78.73 1.69 22.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.197 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.5 120.95 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.52 -32.48 74.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.57 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.6 t -64.04 -43.52 95.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.35 -28.5 53.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.481 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.321 0 O-C-N 119.944 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.23 53.15 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.85 129.64 90.25 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.569 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.79 -22.41 36.9 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.618 2.212 . . . . 0.0 112.398 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.6 129.06 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -45.41 98.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.068 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -107.82 112.09 62.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.099 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 -22.03 38.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.439 2.093 . . . . 0.0 112.557 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -72.78 -17.86 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.638 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.58 -6.25 23.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.684 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.6 m -128.24 68.02 76.05 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-O 121.095 0.474 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -19.77 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.285 2.656 . . . . 0.0 112.074 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -79.57 2.64 21.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.883 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -108.91 112.99 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -57.97 -32.86 68.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.768 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.974 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -80.22 -20.33 44.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.726 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 120.051 -1.656 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.75 -178.31 51.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -64.41 130.25 94.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.911 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.01 -22.52 26.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.837 1.691 . . . . 0.0 112.355 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -78.08 128.44 33.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.391 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.85 -45.35 99.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.24 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -107.16 108.22 61.6 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.39 -21.83 46.51 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.837 1.692 . . . . 0.0 112.516 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.53 -21.28 62.75 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.2 mt -99.07 -2.99 35.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.7 m -129.67 68.3 80.34 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 121.363 0.601 . . . . 0.0 110.581 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.76 -22.28 32.31 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.003 2.469 . . . . 0.0 111.881 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -78.49 -0.29 28.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.599 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -105.36 121.14 57.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.04 -32.52 74.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.031 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m -79.62 -24.04 42.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.517 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 120.052 -1.655 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.035 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.66 -178.93 52.71 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -62.23 129.73 92.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.028 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.1 -23.92 60.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.14 1.893 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 m -84.5 128.26 34.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.328 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.33 -44.54 99.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.984 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -106.79 108.83 62.58 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.024 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.57 -21.77 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.021 1.814 . . . . 0.0 112.926 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -18.56 62.96 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.692 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.25 -5.14 25.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.331 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.28 67.3 78.45 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.239 0.542 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.47 -21.31 40.55 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.24 2.627 . . . . 0.0 112.309 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -80.58 3.71 20.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.58 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.1 mm -108.76 120.8 60.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.979 0.419 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -63.15 -31.72 72.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.09 -39.69 93.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.01 -23.04 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.293 0 O-C-N 120.191 -1.568 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.41 -168.05 53.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.86 129.51 93.2 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.784 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.86 -22.12 43.13 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.048 1.832 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.31 129.07 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.17 -45.26 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.06 109.28 61.93 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.87 -23.53 47.48 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.023 1.815 . . . . 0.0 112.506 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -70.35 -20.97 62.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.402 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.92 -6.1 29.5 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.8 m -129.05 67.28 78.13 Favored Pre-proline 0 C--N 1.335 -0.032 0 CA-C-O 121.351 0.596 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -20.88 33.68 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.17 2.58 . . . . 0.0 111.825 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -79.19 0.31 28.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.296 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -105.36 113.85 43.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -57.38 -32.28 66.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.2 t -64.87 -40.23 94.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.44 -30.32 37.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.31 0 O-C-N 120.147 -1.596 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.8 -171.46 43.01 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.3 t -62.86 129.42 93.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.859 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -20.87 33.95 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.284 1.99 . . . . 0.0 112.411 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.0 m -82.67 128.21 34.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.241 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.21 -45.4 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.914 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.97 109.9 62.14 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.937 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.54 -21.98 52.01 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.211 1.941 . . . . 0.0 112.788 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -71.1 -19.48 62.45 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.416 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.15 -4.77 28.96 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.5 m -129.23 66.95 77.83 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 121.177 0.513 . . . . 0.0 110.331 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.2 -20.53 37.33 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.317 2.678 . . . . 0.0 111.874 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -81.65 5.75 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mm -110.62 121.09 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -63.57 -32.21 73.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.576 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.4 m -64.59 -39.95 94.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.37 -13.29 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.466 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.316 0 O-C-N 120.129 -1.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.3 178.92 48.68 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t -65.51 129.73 94.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.906 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.37 -20.3 21.15 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.987 2.458 . . . . 0.0 112.263 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 131.61 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.8 -43.95 98.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.37 . . . . 0.0 110.472 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -109.64 112.17 58.75 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.195 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.99 -22.17 31.39 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.606 2.204 . . . . 0.0 111.838 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.33 -22.14 60.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.751 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt -96.71 -14.93 21.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.1 m -123.3 65.2 29.69 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 121.419 0.628 . . . . 0.0 110.214 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -15.26 33.43 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.366 2.711 . . . . 0.0 112.671 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -85.13 4.01 36.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.808 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -106.56 116.09 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -58.84 -32.12 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.76 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 m -66.51 -38.51 87.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.617 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.18 -12.76 57.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 O-C-N 119.993 -1.692 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' ' 14' ' ' ILE . 35.4 t -62.53 129.06 92.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.453 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.27 -23.04 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.908 2.405 . . . . 0.0 112.203 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.36 129.85 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.21 -44.75 99.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -110.56 112.44 56.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.54 -23.07 32.2 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.885 2.39 . . . . 0.0 111.485 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -72.2 -19.67 61.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.119 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.48 -5.46 25.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.625 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -127.98 67.93 74.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.367 0.604 . . . . 0.0 110.666 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.73 -20.22 35.28 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.86 2.373 . . . . 0.0 112.782 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -81.45 3.54 24.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -108.05 114.55 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -60.51 -32.72 71.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.6 m -63.35 -37.23 86.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.553 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.543 -179.603 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.498 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.1 t -61.73 129.82 91.79 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.24 -24.74 50.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.115 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.54 129.36 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.079 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.2 -45.04 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.58 110.4 62.78 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.95 -23.24 41.01 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.574 2.183 . . . . 0.0 112.632 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -72.3 -19.51 61.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.35 -3.36 27.24 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.8 m -129.51 68.02 79.76 Favored Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 120.985 0.422 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.07 -19.6 34.42 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.123 2.549 . . . . 0.0 112.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -81.09 2.9 25.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.13 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.498 HG21 ' SG ' ' A' ' 3' ' ' CYS . 33.1 mm -108.16 114.43 46.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -59.53 -32.87 70.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.774 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 m -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.656 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.579 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -64.9 129.55 94.48 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.62 -22.07 33.26 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.455 2.103 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 m -81.32 129.59 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.73 -44.93 99.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.764 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.14 111.45 60.25 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.89 -22.15 42.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.148 1.898 . . . . 0.0 112.161 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -71.83 -18.61 62.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -101.09 -5.52 25.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.857 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -129.57 68.35 80.3 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 121.166 0.507 . . . . 0.0 110.571 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.28 -18.51 39.23 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.229 2.619 . . . . 0.0 112.136 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -84.46 4.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.353 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 25.7 mm -110.82 115.01 48.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -60.12 -32.13 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.035 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.2 m -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.301 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.622 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.7 t -61.3 129.65 91.03 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.583 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 -21.8 44.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 m -85.73 128.91 34.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.88 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.133 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -108.13 108.92 61.72 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.026 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 -20.49 54.06 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.853 2.369 . . . . 0.0 112.691 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -74.46 -16.31 60.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.614 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.87 -4.97 22.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.635 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.55 67.72 76.85 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-O 121.23 0.538 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.83 -19.33 35.94 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.926 2.417 . . . . 0.0 112.47 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -81.95 5.8 17.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.3 mm -110.28 121.79 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-O 120.809 0.338 . . . . 0.0 110.099 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -65.87 -32.22 73.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.683 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.5 m -64.65 -39.73 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.519 -179.786 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.381 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' SG ' HG21 ' A' ' 14' ' ' ILE . 19.5 t -61.81 129.6 91.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.601 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.39 -26.17 41.34 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.258 1.972 . . . . 0.0 112.371 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.5 m -78.62 129.47 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -44.41 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.031 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -107.53 111.11 63.0 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.31 -22.53 39.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.808 1.672 . . . . 0.0 111.731 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.42 -21.76 61.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.301 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.98 -15.82 20.91 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.0 m -121.34 66.4 16.99 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.89 -18.23 36.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.415 2.743 . . . . 0.0 111.894 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -82.46 4.42 24.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.511 HG21 ' SG ' ' A' ' 3' ' ' CYS . 26.0 mm -109.22 117.95 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -58.73 -32.77 69.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.817 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.8 m -65.27 -38.13 89.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.813 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.5 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.7 t -65.88 128.62 93.95 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.035 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.79 -19.76 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.69 127.87 34.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.15 -45.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.178 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -107.12 109.26 62.89 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.94 -21.46 49.94 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.272 1.981 . . . . 0.0 112.308 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -72.72 -19.04 61.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.47 -4.59 26.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.119 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.9 m -129.09 67.04 77.82 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 110.535 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 -18.0 38.27 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.849 2.366 . . . . 0.0 111.467 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -81.54 7.16 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.006 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.434 HG21 ' SG ' ' A' ' 3' ' ' CYS . 44.9 mm -113.73 122.48 67.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -65.32 -32.97 74.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.53 -40.03 94.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.1 t -62.29 129.58 92.43 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.698 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.09 -21.22 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.638 2.226 . . . . 0.0 112.62 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.92 129.67 34.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.03 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.329 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -107.97 110.15 62.2 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.739 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.74 -24.05 47.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.818 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -71.76 -18.4 62.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.41 -5.66 25.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.808 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -128.58 67.82 77.15 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 121.175 0.512 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.14 -19.02 34.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.131 2.554 . . . . 0.0 112.102 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -80.69 3.17 23.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.7 mm -108.23 120.18 59.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -63.73 -31.77 73.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.549 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -65.36 -40.09 93.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.725 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.388 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.7 t -62.72 129.37 92.89 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.25 -20.4 32.58 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.0 1.8 . . . . 0.0 112.416 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.89 129.3 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.305 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -108.11 110.0 62.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.284 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.27 -22.84 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.94 1.76 . . . . 0.0 112.909 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.56 -21.12 61.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.575 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.4 mt -100.0 -2.18 35.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.101 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m -129.07 67.43 78.38 Favored Pre-proline 0 C--O 1.231 0.112 0 CA-C-O 121.224 0.535 . . . . 0.0 110.583 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.95 -21.94 36.58 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.198 2.599 . . . . 0.0 111.777 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -78.16 0.99 22.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.561 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.451 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.5 mm -107.56 119.98 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.24 -32.03 73.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.9 t -63.83 -43.41 96.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.5 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.4 t -53.81 129.68 56.04 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.972 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.24 -23.07 33.59 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.276 1.984 . . . . 0.0 112.599 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.13 128.55 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.67 -45.4 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -107.88 108.03 60.95 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.904 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.3 -22.15 53.47 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.275 1.983 . . . . 0.0 112.884 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.8 -19.8 61.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.428 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -100.15 -3.37 31.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -129.61 67.95 79.8 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 121.095 0.474 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.18 -20.42 37.61 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 123.234 2.623 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -80.48 2.01 27.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.514 HG21 ' SG ' ' A' ' 3' ' ' CYS . 37.8 mm -108.6 114.56 47.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.74 -31.82 69.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.896 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -64.4 -38.11 89.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.485 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.509 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 14' ' ' ILE . 45.9 t -62.51 129.55 92.71 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.976 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -20.33 34.38 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.418 2.079 . . . . 0.0 112.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.4 126.89 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -45.13 99.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -106.3 108.91 62.64 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.935 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.37 -22.46 45.68 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.423 2.082 . . . . 0.0 112.568 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.24 -20.49 61.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.777 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.7 -5.34 28.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.144 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -128.19 67.45 74.89 Favored Pre-proline 0 C--N 1.333 -0.131 0 CA-C-O 121.315 0.578 . . . . 0.0 110.257 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.64 -18.99 37.26 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 123.514 2.809 . . . . 0.0 112.05 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -82.3 4.26 24.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.294 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.418 HG21 ' SG ' ' A' ' 3' ' ' CYS . 40.3 mm -109.11 120.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.876 0.37 . . . . 0.0 110.022 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -64.1 -32.49 74.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.89 -39.61 93.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 -179.688 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -63.94 129.49 93.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.807 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.22 -21.66 31.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.897 1.731 . . . . 0.0 112.396 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.43 129.21 34.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.41 -45.2 99.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.252 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -107.5 109.9 62.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.243 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.96 -22.49 41.98 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.932 1.754 . . . . 0.0 112.514 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.11 -20.75 62.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.564 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.9 mt -99.53 -4.64 30.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.999 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.33 67.26 78.47 Favored Pre-proline 0 C--O 1.232 0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.495 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.35 -21.96 34.63 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 123.19 2.593 . . . . 0.0 111.928 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -78.65 1.88 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.522 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 3' ' ' CYS . 43.1 mm -107.07 121.61 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -64.12 -32.65 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.3 m -64.96 -40.0 94.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.629 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 14' ' ' ILE . 46.1 t -65.29 129.78 94.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.844 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.53 -22.67 28.22 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.013 1.809 . . . . 0.0 111.968 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 m -81.03 127.27 32.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.309 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.83 -45.07 99.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.913 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -106.91 110.76 63.79 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.83 -20.61 39.24 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.024 1.816 . . . . 0.0 112.48 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -72.39 -19.27 61.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.631 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.25 -4.01 27.92 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.175 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -129.42 67.37 78.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.145 0.498 . . . . 0.0 110.643 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.43 -20.31 36.53 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.129 2.553 . . . . 0.0 112.039 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -80.57 3.65 21.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.318 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 ' SG ' ' A' ' 3' ' ' CYS . 46.3 mm -108.88 121.63 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -64.89 -31.89 73.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.966 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.49 -39.86 92.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.458 -179.822 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.528 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.463 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.7 t -64.64 129.28 94.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.636 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 -24.7 27.07 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.14 1.894 . . . . 0.0 112.112 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.38 128.42 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.66 -45.56 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.43 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -108.28 110.1 61.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 -22.63 47.18 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.14 1.893 . . . . 0.0 112.553 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.51 -20.02 61.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.26 -3.54 31.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.022 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -129.49 68.59 80.55 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.033 0.444 . . . . 0.0 110.669 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 -22.04 38.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.122 2.548 . . . . 0.0 112.119 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -79.29 3.13 18.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.5 mm -109.59 114.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 110.291 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.6 -31.41 70.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.66 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -64.38 -37.74 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.454 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.573 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.6 t -61.68 129.64 91.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.711 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.83 -21.4 33.24 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.017 1.811 . . . . 0.0 112.542 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -82.88 129.44 35.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.59 -45.23 99.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.139 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -107.72 110.23 62.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.27 -21.82 47.29 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.905 1.736 . . . . 0.0 112.524 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.33 -20.62 61.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.341 . . . . 0.0 110.743 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.87 -3.77 31.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.199 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 88.3 m -129.48 67.34 78.78 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 121.226 0.536 . . . . 0.0 110.517 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.56 -20.96 35.1 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.313 2.675 . . . . 0.0 111.754 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -78.73 1.69 22.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.197 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.9 mm -107.5 120.95 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.52 -32.48 74.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.57 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.6 t -64.04 -43.52 95.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.481 -179.805 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.332 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.3 t -60.85 129.64 90.25 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.569 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.79 -22.41 36.9 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.618 2.212 . . . . 0.0 112.398 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.6 129.06 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -45.41 98.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.068 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -107.82 112.09 62.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.099 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 -22.03 38.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.439 2.093 . . . . 0.0 112.557 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -72.78 -17.86 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.638 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.58 -6.25 23.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.684 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.6 m -128.24 68.02 76.05 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-O 121.095 0.474 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -19.77 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.285 2.656 . . . . 0.0 112.074 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -79.57 2.64 21.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.883 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -108.91 112.99 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -57.97 -32.86 68.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.768 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.974 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.726 -179.442 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -64.41 130.25 94.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.911 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.01 -22.52 26.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.837 1.691 . . . . 0.0 112.355 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -78.08 128.44 33.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.391 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.85 -45.35 99.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.24 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -107.16 108.22 61.6 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.39 -21.83 46.51 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.837 1.692 . . . . 0.0 112.516 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.53 -21.28 62.75 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.2 mt -99.07 -2.99 35.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.7 m -129.67 68.3 80.34 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 121.363 0.601 . . . . 0.0 110.581 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.76 -22.28 32.31 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.003 2.469 . . . . 0.0 111.881 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -78.49 -0.29 28.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.599 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.488 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -105.36 121.14 57.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.04 -32.52 74.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.031 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.517 -179.791 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -62.23 129.73 92.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.028 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.1 -23.92 60.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.14 1.893 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 m -84.5 128.26 34.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.328 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.33 -44.54 99.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.984 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -106.79 108.83 62.58 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.024 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.57 -21.77 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.021 1.814 . . . . 0.0 112.926 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -18.56 62.96 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.692 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.25 -5.14 25.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.331 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.28 67.3 78.45 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.239 0.542 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.47 -21.31 40.55 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.24 2.627 . . . . 0.0 112.309 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -80.58 3.71 20.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.58 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.417 HG21 ' SG ' ' A' ' 3' ' ' CYS . 27.1 mm -108.76 120.8 60.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.979 0.419 . . . . 0.0 109.891 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -63.15 -31.72 72.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.09 -39.69 93.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.78 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.596 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 14' ' ' ILE . 41.9 t -62.86 129.51 93.2 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.784 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.86 -22.12 43.13 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.048 1.832 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.31 129.07 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.17 -45.26 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.06 109.28 61.93 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.87 -23.53 47.48 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.023 1.815 . . . . 0.0 112.506 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -70.35 -20.97 62.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.402 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.92 -6.1 29.5 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.8 m -129.05 67.28 78.13 Favored Pre-proline 0 C--N 1.335 -0.032 0 CA-C-O 121.351 0.596 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -20.88 33.68 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.17 2.58 . . . . 0.0 111.825 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -79.19 0.31 28.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.296 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.2 mm -105.36 113.85 43.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -57.38 -32.28 66.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.2 t -64.87 -40.23 94.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -179.427 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 38.3 t -62.86 129.42 93.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -20.87 33.95 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.284 1.99 . . . . 0.0 112.411 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.0 m -82.67 128.21 34.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.241 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.21 -45.4 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.914 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.97 109.9 62.14 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.937 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.54 -21.98 52.01 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.211 1.941 . . . . 0.0 112.788 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -71.1 -19.48 62.45 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.416 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.15 -4.77 28.96 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.5 m -129.23 66.95 77.83 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 121.177 0.513 . . . . 0.0 110.331 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.2 -20.53 37.33 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.317 2.678 . . . . 0.0 111.874 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -81.65 5.75 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -110.62 121.09 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -63.57 -32.21 73.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.576 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.4 m -64.59 -39.95 94.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.466 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.8 t -65.51 129.73 94.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.906 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.37 -20.3 21.15 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.987 2.458 . . . . 0.0 112.263 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 131.61 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.8 -43.95 98.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.37 . . . . 0.0 110.472 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.434 ' HB2' HD12 ' A' ' 10' ' ' LEU . 86.8 m95 -109.64 112.17 58.75 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.195 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.99 -22.17 31.39 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.606 2.204 . . . . 0.0 111.838 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.33 -22.14 60.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.751 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 7' ' ' TRP . 82.5 mt -96.71 -14.93 21.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.261 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.1 m -123.3 65.2 29.69 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 121.419 0.628 . . . . 0.0 110.214 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -15.26 33.43 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.366 2.711 . . . . 0.0 112.671 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -85.13 4.01 36.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.808 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 17' ' ' CYS . 44.2 mm -106.56 116.09 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.692 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -58.84 -32.12 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.76 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 m -66.51 -38.51 87.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.617 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.59 178.01 53.96 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' ' 14' ' ' ILE . 35.4 t -62.53 129.06 92.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.453 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.27 -23.04 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.908 2.405 . . . . 0.0 112.203 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.36 129.85 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.21 -44.75 99.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -110.56 112.44 56.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.54 -23.07 32.2 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.885 2.39 . . . . 0.0 111.485 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -72.2 -19.67 61.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.119 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.48 -5.46 25.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.625 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -127.98 67.93 74.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.367 0.604 . . . . 0.0 110.666 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.73 -20.22 35.28 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.86 2.373 . . . . 0.0 112.782 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -81.45 3.54 24.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -108.05 114.55 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -60.51 -32.72 71.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.6 m -63.35 -37.23 86.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.553 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.71 -17.88 39.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.543 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 120.092 -1.63 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.69 174.78 42.1 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.498 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.1 t -61.73 129.82 91.79 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.24 -24.74 50.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.115 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.54 129.36 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.079 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.2 -45.04 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.58 110.4 62.78 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.95 -23.24 41.01 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.574 2.183 . . . . 0.0 112.632 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -72.3 -19.51 61.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.35 -3.36 27.24 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.8 m -129.51 68.02 79.76 Favored Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 120.985 0.422 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.07 -19.6 34.42 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.123 2.549 . . . . 0.0 112.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -81.09 2.9 25.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.13 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.498 HG21 ' SG ' ' A' ' 3' ' ' CYS . 33.1 mm -108.16 114.43 46.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -59.53 -32.87 70.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.774 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 m -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.656 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.9 m -82.28 -26.01 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.579 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 O-C-N 120.041 -1.662 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.68 166.63 36.8 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -64.9 129.55 94.48 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.62 -22.07 33.26 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.455 2.103 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 m -81.32 129.59 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.73 -44.93 99.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.764 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.14 111.45 60.25 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.89 -22.15 42.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.148 1.898 . . . . 0.0 112.161 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -71.83 -18.61 62.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -101.09 -5.52 25.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.857 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -129.57 68.35 80.3 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 121.166 0.507 . . . . 0.0 110.571 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.28 -18.51 39.23 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.229 2.619 . . . . 0.0 112.136 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -84.46 4.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.353 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 25.7 mm -110.82 115.01 48.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -60.12 -32.13 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.035 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.2 m -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.301 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.94 -7.26 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.622 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 O-C-N 119.956 -1.715 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.64 -173.88 53.99 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.7 t -61.3 129.65 91.03 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.583 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 -21.8 44.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 m -85.73 128.91 34.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.88 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.133 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -108.13 108.92 61.72 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.026 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 -20.49 54.06 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.853 2.369 . . . . 0.0 112.691 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -74.46 -16.31 60.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.614 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.87 -4.97 22.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.635 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.55 67.72 76.85 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-O 121.23 0.538 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.83 -19.33 35.94 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.926 2.417 . . . . 0.0 112.47 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -81.95 5.8 17.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.3 mm -110.28 121.79 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-O 120.809 0.338 . . . . 0.0 110.099 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -65.87 -32.22 73.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.683 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.5 m -64.65 -39.73 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 m -81.32 -22.25 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.519 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.33 0 O-C-N 120.055 -1.653 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.053 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.67 -171.46 52.73 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' SG ' HG21 ' A' ' 14' ' ' ILE . 19.5 t -61.81 129.6 91.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.601 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.39 -26.17 41.34 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.258 1.972 . . . . 0.0 112.371 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.5 m -78.62 129.47 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -44.41 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.031 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -107.53 111.11 63.0 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.31 -22.53 39.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.808 1.672 . . . . 0.0 111.731 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.42 -21.76 61.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.301 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.98 -15.82 20.91 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.0 m -121.34 66.4 16.99 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.89 -18.23 36.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.415 2.743 . . . . 0.0 111.894 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -82.46 4.42 24.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.511 HG21 ' SG ' ' A' ' 3' ' ' CYS . 26.0 mm -109.22 117.95 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -58.73 -32.77 69.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.817 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.8 m -65.27 -38.13 89.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.813 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -80.96 -17.25 51.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.5 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.357 0 O-C-N 120.082 -1.636 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.66 -177.54 53.42 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.7 t -65.88 128.62 93.95 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.035 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.79 -19.76 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.69 127.87 34.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.15 -45.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.178 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -107.12 109.26 62.89 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.94 -21.46 49.94 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.272 1.981 . . . . 0.0 112.308 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -72.72 -19.04 61.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.47 -4.59 26.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.119 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.9 m -129.09 67.04 77.82 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 110.535 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 -18.0 38.27 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.849 2.366 . . . . 0.0 111.467 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -81.54 7.16 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.006 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.434 HG21 ' SG ' ' A' ' 3' ' ' CYS . 44.9 mm -113.73 122.48 67.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -65.32 -32.97 74.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.53 -40.03 94.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.76 -15.33 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 O-C-N 119.913 -1.742 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.29 -175.64 47.55 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.1 t -62.29 129.58 92.43 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.698 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.09 -21.22 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.638 2.226 . . . . 0.0 112.62 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.92 129.67 34.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.03 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.329 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -107.97 110.15 62.2 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.739 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.74 -24.05 47.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.818 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -71.76 -18.4 62.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.41 -5.66 25.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.808 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -128.58 67.82 77.15 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 121.175 0.512 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.14 -19.02 34.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.131 2.554 . . . . 0.0 112.102 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -80.69 3.17 23.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.7 mm -108.23 120.18 59.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -63.73 -31.77 73.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.549 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -65.36 -40.09 93.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.725 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m -81.1 -2.19 47.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.264 0 O-C-N 119.978 -1.701 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.047 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.16 150.4 16.84 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.7 t -62.72 129.37 92.89 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.25 -20.4 32.58 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.0 1.8 . . . . 0.0 112.416 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.89 129.3 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.305 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -108.11 110.0 62.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.284 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.27 -22.84 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.94 1.76 . . . . 0.0 112.909 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.56 -21.12 61.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.575 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.4 mt -100.0 -2.18 35.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.101 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m -129.07 67.43 78.38 Favored Pre-proline 0 C--O 1.231 0.112 0 CA-C-O 121.224 0.535 . . . . 0.0 110.583 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.95 -21.94 36.58 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.198 2.599 . . . . 0.0 111.777 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -78.16 0.99 22.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.561 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.451 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.5 mm -107.56 119.98 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.24 -32.03 73.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.9 t -63.83 -43.41 96.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.33 -31.64 58.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 O-C-N 120.042 -1.661 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.58 96.65 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.4 t -53.81 129.68 56.04 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.972 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.24 -23.07 33.59 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.276 1.984 . . . . 0.0 112.599 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.13 128.55 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.67 -45.4 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -107.88 108.03 60.95 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.904 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.3 -22.15 53.47 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.275 1.983 . . . . 0.0 112.884 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.8 -19.8 61.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.428 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -100.15 -3.37 31.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -129.61 67.95 79.8 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 121.095 0.474 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.18 -20.42 37.61 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 123.234 2.623 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -80.48 2.01 27.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.514 HG21 ' SG ' ' A' ' 3' ' ' CYS . 37.8 mm -108.6 114.56 47.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.74 -31.82 69.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.896 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -64.4 -38.11 89.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.485 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 m -82.87 -29.31 29.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.509 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.29 0 O-C-N 120.123 -1.61 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.77 48.57 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 14' ' ' ILE . 45.9 t -62.51 129.55 92.71 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.976 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -20.33 34.38 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.418 2.079 . . . . 0.0 112.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.4 126.89 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -45.13 99.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -106.3 108.91 62.64 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.935 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.37 -22.46 45.68 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.423 2.082 . . . . 0.0 112.568 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.24 -20.49 61.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.777 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.7 -5.34 28.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.144 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -128.19 67.45 74.89 Favored Pre-proline 0 C--N 1.333 -0.131 0 CA-C-O 121.315 0.578 . . . . 0.0 110.257 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.64 -18.99 37.26 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 123.514 2.809 . . . . 0.0 112.05 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -82.3 4.26 24.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.294 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.418 HG21 ' SG ' ' A' ' 3' ' ' CYS . 40.3 mm -109.11 120.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.876 0.37 . . . . 0.0 110.022 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -64.1 -32.49 74.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.89 -39.61 93.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.37 -14.69 54.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.286 0 O-C-N 119.914 -1.741 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.11 158.99 53.82 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -63.94 129.49 93.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.807 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.22 -21.66 31.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.897 1.731 . . . . 0.0 112.396 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.43 129.21 34.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.41 -45.2 99.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.252 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -107.5 109.9 62.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.243 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.96 -22.49 41.98 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.932 1.754 . . . . 0.0 112.514 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.11 -20.75 62.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.564 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.9 mt -99.53 -4.64 30.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.999 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.33 67.26 78.47 Favored Pre-proline 0 C--O 1.232 0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.495 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.35 -21.96 34.63 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 123.19 2.593 . . . . 0.0 111.928 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -78.65 1.88 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.522 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 3' ' ' CYS . 43.1 mm -107.07 121.61 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -64.12 -32.65 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.3 m -64.96 -40.0 94.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -81.36 -3.3 52.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 O-C-N 119.983 -1.698 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.26 -179.05 48.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 14' ' ' ILE . 46.1 t -65.29 129.78 94.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.844 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.53 -22.67 28.22 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.013 1.809 . . . . 0.0 111.968 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 m -81.03 127.27 32.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.309 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.83 -45.07 99.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.913 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -106.91 110.76 63.79 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.83 -20.61 39.24 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.024 1.816 . . . . 0.0 112.48 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -72.39 -19.27 61.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.631 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.25 -4.01 27.92 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.175 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -129.42 67.37 78.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.145 0.498 . . . . 0.0 110.643 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.43 -20.31 36.53 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.129 2.553 . . . . 0.0 112.039 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -80.57 3.65 21.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.318 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 ' SG ' ' A' ' 3' ' ' CYS . 46.3 mm -108.88 121.63 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -64.89 -31.89 73.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.966 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.49 -39.86 92.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.26 -27.43 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 120.192 -1.567 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.91 172.2 46.19 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.7 t -64.64 129.28 94.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.636 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 -24.7 27.07 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.14 1.894 . . . . 0.0 112.112 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.38 128.42 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.66 -45.56 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.43 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -108.28 110.1 61.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 -22.63 47.18 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.14 1.893 . . . . 0.0 112.553 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.51 -20.02 61.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.26 -3.54 31.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.022 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -129.49 68.59 80.55 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.033 0.444 . . . . 0.0 110.669 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 -22.04 38.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.122 2.548 . . . . 0.0 112.119 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -79.29 3.13 18.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.5 mm -109.59 114.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 110.291 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.6 -31.41 70.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.66 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -64.38 -37.74 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.454 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m -85.33 -11.82 53.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 O-C-N 120.026 -1.671 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.39 178.56 48.43 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.6 t -61.68 129.64 91.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.711 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.83 -21.4 33.24 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.017 1.811 . . . . 0.0 112.542 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -82.88 129.44 35.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.59 -45.23 99.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.139 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -107.72 110.23 62.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.27 -21.82 47.29 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.905 1.736 . . . . 0.0 112.524 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.33 -20.62 61.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.341 . . . . 0.0 110.743 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.87 -3.77 31.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.199 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 88.3 m -129.48 67.34 78.78 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 121.226 0.536 . . . . 0.0 110.517 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.56 -20.96 35.1 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.313 2.675 . . . . 0.0 111.754 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -78.73 1.69 22.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.197 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.9 mm -107.5 120.95 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.52 -32.48 74.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.57 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.6 t -64.04 -43.52 95.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.35 -28.5 53.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.481 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.321 0 O-C-N 119.944 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.23 53.15 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.3 t -60.85 129.64 90.25 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.569 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.79 -22.41 36.9 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.618 2.212 . . . . 0.0 112.398 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.6 129.06 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -45.41 98.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.068 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -107.82 112.09 62.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.099 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 -22.03 38.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.439 2.093 . . . . 0.0 112.557 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -72.78 -17.86 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.638 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.58 -6.25 23.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.684 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.6 m -128.24 68.02 76.05 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-O 121.095 0.474 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -19.77 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.285 2.656 . . . . 0.0 112.074 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -79.57 2.64 21.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.883 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -108.91 112.99 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -57.97 -32.86 68.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.768 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.974 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -80.22 -20.33 44.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.726 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 120.051 -1.656 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.75 -178.31 51.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -64.41 130.25 94.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.911 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.01 -22.52 26.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.837 1.691 . . . . 0.0 112.355 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -78.08 128.44 33.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.391 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.85 -45.35 99.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.24 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -107.16 108.22 61.6 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.39 -21.83 46.51 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.837 1.692 . . . . 0.0 112.516 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.53 -21.28 62.75 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.2 mt -99.07 -2.99 35.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.7 m -129.67 68.3 80.34 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 121.363 0.601 . . . . 0.0 110.581 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.76 -22.28 32.31 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.003 2.469 . . . . 0.0 111.881 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -78.49 -0.29 28.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.599 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.488 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -105.36 121.14 57.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.04 -32.52 74.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.031 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m -79.62 -24.04 42.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.517 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 120.052 -1.655 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.035 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.66 -178.93 52.71 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -62.23 129.73 92.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.028 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.1 -23.92 60.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.14 1.893 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 m -84.5 128.26 34.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.328 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.33 -44.54 99.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.984 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -106.79 108.83 62.58 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.024 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.57 -21.77 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.021 1.814 . . . . 0.0 112.926 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -18.56 62.96 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.692 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.25 -5.14 25.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.331 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.28 67.3 78.45 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.239 0.542 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.47 -21.31 40.55 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.24 2.627 . . . . 0.0 112.309 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -80.58 3.71 20.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.58 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.417 HG21 ' SG ' ' A' ' 3' ' ' CYS . 27.1 mm -108.76 120.8 60.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.979 0.419 . . . . 0.0 109.891 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -63.15 -31.72 72.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.09 -39.69 93.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.01 -23.04 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.293 0 O-C-N 120.191 -1.568 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.41 -168.05 53.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 14' ' ' ILE . 41.9 t -62.86 129.51 93.2 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.784 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.86 -22.12 43.13 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.048 1.832 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.31 129.07 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.17 -45.26 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.06 109.28 61.93 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.87 -23.53 47.48 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.023 1.815 . . . . 0.0 112.506 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -70.35 -20.97 62.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.402 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.92 -6.1 29.5 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.8 m -129.05 67.28 78.13 Favored Pre-proline 0 C--N 1.335 -0.032 0 CA-C-O 121.351 0.596 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -20.88 33.68 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.17 2.58 . . . . 0.0 111.825 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -79.19 0.31 28.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.296 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.2 mm -105.36 113.85 43.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -57.38 -32.28 66.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.2 t -64.87 -40.23 94.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.44 -30.32 37.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.31 0 O-C-N 120.147 -1.596 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.8 -171.46 43.01 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 38.3 t -62.86 129.42 93.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -20.87 33.95 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.284 1.99 . . . . 0.0 112.411 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.0 m -82.67 128.21 34.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.241 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.21 -45.4 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.914 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.97 109.9 62.14 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.937 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.54 -21.98 52.01 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.211 1.941 . . . . 0.0 112.788 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -71.1 -19.48 62.45 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.416 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.15 -4.77 28.96 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.5 m -129.23 66.95 77.83 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 121.177 0.513 . . . . 0.0 110.331 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.2 -20.53 37.33 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.317 2.678 . . . . 0.0 111.874 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -81.65 5.75 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -110.62 121.09 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -63.57 -32.21 73.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.576 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.4 m -64.59 -39.95 94.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.37 -13.29 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.466 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.316 0 O-C-N 120.129 -1.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.3 178.92 48.68 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.8 t -65.51 129.73 94.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.906 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.37 -20.3 21.15 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.987 2.458 . . . . 0.0 112.263 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 131.61 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.8 -43.95 98.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.37 . . . . 0.0 110.472 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.434 ' HB2' HD12 ' A' ' 10' ' ' LEU . 86.8 m95 -109.64 112.17 58.75 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.195 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.99 -22.17 31.39 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.606 2.204 . . . . 0.0 111.838 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.33 -22.14 60.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.751 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 7' ' ' TRP . 82.5 mt -96.71 -14.93 21.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.261 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.1 m -123.3 65.2 29.69 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 121.419 0.628 . . . . 0.0 110.214 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -15.26 33.43 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.366 2.711 . . . . 0.0 112.671 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -85.13 4.01 36.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.808 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 17' ' ' CYS . 44.2 mm -106.56 116.09 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.692 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -58.84 -32.12 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.76 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 m -66.51 -38.51 87.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.617 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m -82.18 -12.76 57.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 O-C-N 119.993 -1.692 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' ' 14' ' ' ILE . 35.4 t -62.53 129.06 92.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.453 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.27 -23.04 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.908 2.405 . . . . 0.0 112.203 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.36 129.85 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.21 -44.75 99.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -110.56 112.44 56.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.54 -23.07 32.2 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.885 2.39 . . . . 0.0 111.485 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -72.2 -19.67 61.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.119 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.48 -5.46 25.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.625 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -127.98 67.93 74.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.367 0.604 . . . . 0.0 110.666 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.73 -20.22 35.28 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.86 2.373 . . . . 0.0 112.782 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -81.45 3.54 24.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -108.05 114.55 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -60.51 -32.72 71.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.6 m -63.35 -37.23 86.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.553 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.543 -179.603 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.498 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.1 t -61.73 129.82 91.79 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.24 -24.74 50.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.115 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.54 129.36 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.079 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.2 -45.04 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.58 110.4 62.78 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.95 -23.24 41.01 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.574 2.183 . . . . 0.0 112.632 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -72.3 -19.51 61.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.35 -3.36 27.24 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.8 m -129.51 68.02 79.76 Favored Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 120.985 0.422 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.07 -19.6 34.42 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.123 2.549 . . . . 0.0 112.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -81.09 2.9 25.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.13 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.498 HG21 ' SG ' ' A' ' 3' ' ' CYS . 33.1 mm -108.16 114.43 46.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -59.53 -32.87 70.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.774 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 m -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.656 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.579 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -64.9 129.55 94.48 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.62 -22.07 33.26 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.455 2.103 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 m -81.32 129.59 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.73 -44.93 99.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.764 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.14 111.45 60.25 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.89 -22.15 42.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.148 1.898 . . . . 0.0 112.161 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -71.83 -18.61 62.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -101.09 -5.52 25.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.857 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -129.57 68.35 80.3 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 121.166 0.507 . . . . 0.0 110.571 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.28 -18.51 39.23 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.229 2.619 . . . . 0.0 112.136 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -84.46 4.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.353 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 25.7 mm -110.82 115.01 48.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -60.12 -32.13 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.035 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.2 m -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.301 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.622 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.7 t -61.3 129.65 91.03 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.583 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 -21.8 44.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 m -85.73 128.91 34.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.88 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.133 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -108.13 108.92 61.72 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.026 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 -20.49 54.06 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.853 2.369 . . . . 0.0 112.691 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -74.46 -16.31 60.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.614 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.87 -4.97 22.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.635 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.55 67.72 76.85 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-O 121.23 0.538 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.83 -19.33 35.94 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.926 2.417 . . . . 0.0 112.47 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -81.95 5.8 17.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.3 mm -110.28 121.79 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-O 120.809 0.338 . . . . 0.0 110.099 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -65.87 -32.22 73.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.683 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.5 m -64.65 -39.73 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.519 -179.786 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.381 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' SG ' HG21 ' A' ' 14' ' ' ILE . 19.5 t -61.81 129.6 91.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.601 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.39 -26.17 41.34 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.258 1.972 . . . . 0.0 112.371 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.5 m -78.62 129.47 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -44.41 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.031 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -107.53 111.11 63.0 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.31 -22.53 39.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.808 1.672 . . . . 0.0 111.731 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.42 -21.76 61.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.301 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.98 -15.82 20.91 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.0 m -121.34 66.4 16.99 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.89 -18.23 36.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.415 2.743 . . . . 0.0 111.894 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -82.46 4.42 24.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.511 HG21 ' SG ' ' A' ' 3' ' ' CYS . 26.0 mm -109.22 117.95 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -58.73 -32.77 69.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.817 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.8 m -65.27 -38.13 89.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.813 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.5 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.7 t -65.88 128.62 93.95 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.035 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.79 -19.76 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.69 127.87 34.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.15 -45.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.178 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -107.12 109.26 62.89 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.94 -21.46 49.94 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.272 1.981 . . . . 0.0 112.308 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -72.72 -19.04 61.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.47 -4.59 26.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.119 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.9 m -129.09 67.04 77.82 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 110.535 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 -18.0 38.27 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.849 2.366 . . . . 0.0 111.467 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -81.54 7.16 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.006 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.434 HG21 ' SG ' ' A' ' 3' ' ' CYS . 44.9 mm -113.73 122.48 67.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -65.32 -32.97 74.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.53 -40.03 94.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.1 t -62.29 129.58 92.43 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.698 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.09 -21.22 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.638 2.226 . . . . 0.0 112.62 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.92 129.67 34.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.03 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.329 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -107.97 110.15 62.2 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.739 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.74 -24.05 47.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.818 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -71.76 -18.4 62.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.41 -5.66 25.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.808 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -128.58 67.82 77.15 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 121.175 0.512 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.14 -19.02 34.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.131 2.554 . . . . 0.0 112.102 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -80.69 3.17 23.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.7 mm -108.23 120.18 59.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -63.73 -31.77 73.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.549 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -65.36 -40.09 93.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.725 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.388 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.7 t -62.72 129.37 92.89 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.25 -20.4 32.58 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.0 1.8 . . . . 0.0 112.416 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.89 129.3 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.305 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -108.11 110.0 62.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.284 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.27 -22.84 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.94 1.76 . . . . 0.0 112.909 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.56 -21.12 61.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.575 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.4 mt -100.0 -2.18 35.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.101 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m -129.07 67.43 78.38 Favored Pre-proline 0 C--O 1.231 0.112 0 CA-C-O 121.224 0.535 . . . . 0.0 110.583 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.95 -21.94 36.58 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.198 2.599 . . . . 0.0 111.777 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -78.16 0.99 22.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.561 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.451 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.5 mm -107.56 119.98 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.24 -32.03 73.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.9 t -63.83 -43.41 96.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.5 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.4 t -53.81 129.68 56.04 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.972 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.24 -23.07 33.59 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.276 1.984 . . . . 0.0 112.599 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.13 128.55 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.67 -45.4 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -107.88 108.03 60.95 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.904 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.3 -22.15 53.47 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.275 1.983 . . . . 0.0 112.884 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.8 -19.8 61.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.428 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -100.15 -3.37 31.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -129.61 67.95 79.8 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 121.095 0.474 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.18 -20.42 37.61 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 123.234 2.623 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -80.48 2.01 27.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.514 HG21 ' SG ' ' A' ' 3' ' ' CYS . 37.8 mm -108.6 114.56 47.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.74 -31.82 69.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.896 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -64.4 -38.11 89.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.485 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.509 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 14' ' ' ILE . 45.9 t -62.51 129.55 92.71 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.976 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -20.33 34.38 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.418 2.079 . . . . 0.0 112.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.4 126.89 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -45.13 99.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -106.3 108.91 62.64 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.935 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.37 -22.46 45.68 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.423 2.082 . . . . 0.0 112.568 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.24 -20.49 61.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.777 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.7 -5.34 28.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.144 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -128.19 67.45 74.89 Favored Pre-proline 0 C--N 1.333 -0.131 0 CA-C-O 121.315 0.578 . . . . 0.0 110.257 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.64 -18.99 37.26 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 123.514 2.809 . . . . 0.0 112.05 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -82.3 4.26 24.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.294 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.418 HG21 ' SG ' ' A' ' 3' ' ' CYS . 40.3 mm -109.11 120.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.876 0.37 . . . . 0.0 110.022 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -64.1 -32.49 74.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.89 -39.61 93.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 -179.688 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -63.94 129.49 93.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.807 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.22 -21.66 31.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.897 1.731 . . . . 0.0 112.396 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.43 129.21 34.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.41 -45.2 99.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.252 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -107.5 109.9 62.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.243 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.96 -22.49 41.98 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.932 1.754 . . . . 0.0 112.514 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.11 -20.75 62.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.564 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.9 mt -99.53 -4.64 30.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.999 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.33 67.26 78.47 Favored Pre-proline 0 C--O 1.232 0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.495 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.35 -21.96 34.63 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 123.19 2.593 . . . . 0.0 111.928 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -78.65 1.88 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.522 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 3' ' ' CYS . 43.1 mm -107.07 121.61 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -64.12 -32.65 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.3 m -64.96 -40.0 94.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.629 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 14' ' ' ILE . 46.1 t -65.29 129.78 94.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.844 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.53 -22.67 28.22 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.013 1.809 . . . . 0.0 111.968 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 m -81.03 127.27 32.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.309 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.83 -45.07 99.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.913 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -106.91 110.76 63.79 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.83 -20.61 39.24 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.024 1.816 . . . . 0.0 112.48 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -72.39 -19.27 61.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.631 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.25 -4.01 27.92 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.175 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -129.42 67.37 78.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.145 0.498 . . . . 0.0 110.643 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.43 -20.31 36.53 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.129 2.553 . . . . 0.0 112.039 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -80.57 3.65 21.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.318 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 ' SG ' ' A' ' 3' ' ' CYS . 46.3 mm -108.88 121.63 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -64.89 -31.89 73.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.966 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.49 -39.86 92.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.458 -179.822 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.528 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.463 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.7 t -64.64 129.28 94.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.636 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 -24.7 27.07 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.14 1.894 . . . . 0.0 112.112 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.38 128.42 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.66 -45.56 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.43 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -108.28 110.1 61.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 -22.63 47.18 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.14 1.893 . . . . 0.0 112.553 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.51 -20.02 61.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.26 -3.54 31.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.022 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -129.49 68.59 80.55 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.033 0.444 . . . . 0.0 110.669 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 -22.04 38.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.122 2.548 . . . . 0.0 112.119 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -79.29 3.13 18.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.5 mm -109.59 114.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 110.291 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.6 -31.41 70.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.66 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -64.38 -37.74 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.454 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.573 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.6 t -61.68 129.64 91.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.711 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.83 -21.4 33.24 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.017 1.811 . . . . 0.0 112.542 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -82.88 129.44 35.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.59 -45.23 99.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.139 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -107.72 110.23 62.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.27 -21.82 47.29 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.905 1.736 . . . . 0.0 112.524 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.33 -20.62 61.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.341 . . . . 0.0 110.743 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.87 -3.77 31.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.199 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 88.3 m -129.48 67.34 78.78 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 121.226 0.536 . . . . 0.0 110.517 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.56 -20.96 35.1 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.313 2.675 . . . . 0.0 111.754 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -78.73 1.69 22.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.197 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.9 mm -107.5 120.95 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.52 -32.48 74.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.57 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.6 t -64.04 -43.52 95.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.481 -179.805 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.332 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.3 t -60.85 129.64 90.25 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.569 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.79 -22.41 36.9 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.618 2.212 . . . . 0.0 112.398 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.6 129.06 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -45.41 98.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.068 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -107.82 112.09 62.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.099 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 -22.03 38.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.439 2.093 . . . . 0.0 112.557 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -72.78 -17.86 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.638 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.58 -6.25 23.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.684 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.6 m -128.24 68.02 76.05 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-O 121.095 0.474 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -19.77 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.285 2.656 . . . . 0.0 112.074 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -79.57 2.64 21.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.883 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -108.91 112.99 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -57.97 -32.86 68.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.768 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.974 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.726 -179.442 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -64.41 130.25 94.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.911 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.01 -22.52 26.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.837 1.691 . . . . 0.0 112.355 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -78.08 128.44 33.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.391 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.85 -45.35 99.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.24 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -107.16 108.22 61.6 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.39 -21.83 46.51 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.837 1.692 . . . . 0.0 112.516 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.53 -21.28 62.75 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.2 mt -99.07 -2.99 35.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.7 m -129.67 68.3 80.34 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 121.363 0.601 . . . . 0.0 110.581 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.76 -22.28 32.31 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.003 2.469 . . . . 0.0 111.881 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -78.49 -0.29 28.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.599 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.488 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -105.36 121.14 57.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.04 -32.52 74.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.031 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.517 -179.791 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -62.23 129.73 92.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.028 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.1 -23.92 60.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.14 1.893 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 m -84.5 128.26 34.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.328 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.33 -44.54 99.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.984 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -106.79 108.83 62.58 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.024 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.57 -21.77 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.021 1.814 . . . . 0.0 112.926 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -18.56 62.96 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.692 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.25 -5.14 25.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.331 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.28 67.3 78.45 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.239 0.542 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.47 -21.31 40.55 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.24 2.627 . . . . 0.0 112.309 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -80.58 3.71 20.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.58 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.417 HG21 ' SG ' ' A' ' 3' ' ' CYS . 27.1 mm -108.76 120.8 60.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.979 0.419 . . . . 0.0 109.891 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -63.15 -31.72 72.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.09 -39.69 93.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.78 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.596 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 14' ' ' ILE . 41.9 t -62.86 129.51 93.2 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.784 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.86 -22.12 43.13 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.048 1.832 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.31 129.07 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.17 -45.26 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.06 109.28 61.93 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.87 -23.53 47.48 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.023 1.815 . . . . 0.0 112.506 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -70.35 -20.97 62.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.402 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.92 -6.1 29.5 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.8 m -129.05 67.28 78.13 Favored Pre-proline 0 C--N 1.335 -0.032 0 CA-C-O 121.351 0.596 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -20.88 33.68 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.17 2.58 . . . . 0.0 111.825 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -79.19 0.31 28.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.296 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.2 mm -105.36 113.85 43.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -57.38 -32.28 66.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.2 t -64.87 -40.23 94.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -179.427 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 38.3 t -62.86 129.42 93.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -20.87 33.95 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.284 1.99 . . . . 0.0 112.411 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.0 m -82.67 128.21 34.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.241 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.21 -45.4 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.914 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.97 109.9 62.14 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.937 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.54 -21.98 52.01 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.211 1.941 . . . . 0.0 112.788 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -71.1 -19.48 62.45 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.416 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.15 -4.77 28.96 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.5 m -129.23 66.95 77.83 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 121.177 0.513 . . . . 0.0 110.331 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.2 -20.53 37.33 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.317 2.678 . . . . 0.0 111.874 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -81.65 5.75 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -110.62 121.09 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -63.57 -32.21 73.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.576 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.4 m -64.59 -39.95 94.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.466 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.8 t -65.51 129.73 94.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.906 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.37 -20.3 21.15 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.987 2.458 . . . . 0.0 112.263 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 131.61 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.8 -43.95 98.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.37 . . . . 0.0 110.472 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.434 ' HB2' HD12 ' A' ' 10' ' ' LEU . 86.8 m95 -109.64 112.17 58.75 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.195 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.99 -22.17 31.39 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.606 2.204 . . . . 0.0 111.838 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.33 -22.14 60.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.751 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 7' ' ' TRP . 82.5 mt -96.71 -14.93 21.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.261 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.1 m -123.3 65.2 29.69 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 121.419 0.628 . . . . 0.0 110.214 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -15.26 33.43 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.366 2.711 . . . . 0.0 112.671 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -85.13 4.01 36.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.808 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 17' ' ' CYS . 44.2 mm -106.56 116.09 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.692 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -58.84 -32.12 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.76 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 m -66.51 -38.51 87.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.617 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.59 178.01 53.96 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' ' 14' ' ' ILE . 35.4 t -62.53 129.06 92.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.453 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.27 -23.04 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.908 2.405 . . . . 0.0 112.203 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.36 129.85 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.21 -44.75 99.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -110.56 112.44 56.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.54 -23.07 32.2 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.885 2.39 . . . . 0.0 111.485 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -72.2 -19.67 61.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.119 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -101.48 -5.46 25.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.625 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -127.98 67.93 74.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.367 0.604 . . . . 0.0 110.666 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.73 -20.22 35.28 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.86 2.373 . . . . 0.0 112.782 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -81.45 3.54 24.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -108.05 114.55 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -60.51 -32.72 71.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.6 m -63.35 -37.23 86.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.553 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.71 -17.88 39.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.543 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 120.092 -1.63 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.69 174.78 42.1 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.498 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.1 t -61.73 129.82 91.79 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -66.24 -24.74 50.65 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.115 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.54 129.36 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.079 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.2 -45.04 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.091 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.58 110.4 62.78 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.95 -23.24 41.01 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.574 2.183 . . . . 0.0 112.632 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -72.3 -19.51 61.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.35 -3.36 27.24 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.8 m -129.51 68.02 79.76 Favored Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 120.985 0.422 . . . . 0.0 110.686 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.07 -19.6 34.42 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.123 2.549 . . . . 0.0 112.439 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -81.09 2.9 25.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.13 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.498 HG21 ' SG ' ' A' ' 3' ' ' CYS . 33.1 mm -108.16 114.43 46.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -59.53 -32.87 70.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.774 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 m -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.656 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.9 m -82.28 -26.01 33.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.579 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 O-C-N 120.041 -1.662 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.68 166.63 36.8 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -64.9 129.55 94.48 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.62 -22.07 33.26 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.455 2.103 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 m -81.32 129.59 34.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.73 -44.93 99.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.764 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.14 111.45 60.25 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.89 -22.15 42.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.148 1.898 . . . . 0.0 112.161 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -71.83 -18.61 62.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.254 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -101.09 -5.52 25.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.857 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -129.57 68.35 80.3 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 121.166 0.507 . . . . 0.0 110.571 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.28 -18.51 39.23 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.229 2.619 . . . . 0.0 112.136 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -84.46 4.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.353 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 25.7 mm -110.82 115.01 48.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -60.12 -32.13 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.035 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.2 m -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.301 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.94 -7.26 59.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.622 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 O-C-N 119.956 -1.715 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.64 -173.88 53.99 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.7 t -61.3 129.65 91.03 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.583 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 -21.8 44.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.71 2.273 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 m -85.73 128.91 34.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.88 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.133 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -108.13 108.92 61.72 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.026 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 -20.49 54.06 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.853 2.369 . . . . 0.0 112.691 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -74.46 -16.31 60.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.614 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.87 -4.97 22.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.635 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.55 67.72 76.85 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-O 121.23 0.538 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.83 -19.33 35.94 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.926 2.417 . . . . 0.0 112.47 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -81.95 5.8 17.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.3 mm -110.28 121.79 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-O 120.809 0.338 . . . . 0.0 110.099 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -65.87 -32.22 73.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.683 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.5 m -64.65 -39.73 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 m -81.32 -22.25 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.519 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.33 0 O-C-N 120.055 -1.653 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.053 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.67 -171.46 52.73 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' SG ' HG21 ' A' ' 14' ' ' ILE . 19.5 t -61.81 129.6 91.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.601 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.39 -26.17 41.34 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.258 1.972 . . . . 0.0 112.371 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.5 m -78.62 129.47 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -44.41 99.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.031 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -107.53 111.11 63.0 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.31 -22.53 39.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.808 1.672 . . . . 0.0 111.731 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.42 -21.76 61.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.301 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.98 -15.82 20.91 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.0 m -121.34 66.4 16.99 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.127 0.489 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.89 -18.23 36.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.415 2.743 . . . . 0.0 111.894 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -82.46 4.42 24.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.511 HG21 ' SG ' ' A' ' 3' ' ' CYS . 26.0 mm -109.22 117.95 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -58.73 -32.77 69.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.817 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.8 m -65.27 -38.13 89.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.813 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.6 m -80.96 -17.25 51.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.5 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.357 0 O-C-N 120.082 -1.636 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.66 -177.54 53.42 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' HG21 ' A' ' 14' ' ' ILE . 43.7 t -65.88 128.62 93.95 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.035 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.79 -19.76 30.8 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.45 2.1 . . . . 0.0 112.325 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.69 127.87 34.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.15 -45.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.178 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -107.12 109.26 62.89 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.94 -21.46 49.94 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.272 1.981 . . . . 0.0 112.308 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -72.72 -19.04 61.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.47 -4.59 26.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.119 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.9 m -129.09 67.04 77.82 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-O 121.132 0.491 . . . . 0.0 110.535 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 -18.0 38.27 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.849 2.366 . . . . 0.0 111.467 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -81.54 7.16 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.006 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.434 HG21 ' SG ' ' A' ' 3' ' ' CYS . 44.9 mm -113.73 122.48 67.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -65.32 -32.97 74.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.53 -40.03 94.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.76 -15.33 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.411 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 O-C-N 119.913 -1.742 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.29 -175.64 47.55 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.1 t -62.29 129.58 92.43 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.698 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.09 -21.22 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.638 2.226 . . . . 0.0 112.62 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.92 129.67 34.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.03 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.329 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -107.97 110.15 62.2 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.739 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.74 -24.05 47.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.818 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -71.76 -18.4 62.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.41 -5.66 25.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.808 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -128.58 67.82 77.15 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 121.175 0.512 . . . . 0.0 110.282 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.14 -19.02 34.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.131 2.554 . . . . 0.0 112.102 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -80.69 3.17 23.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.7 mm -108.23 120.18 59.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -63.73 -31.77 73.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.549 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -65.36 -40.09 93.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.725 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m -81.1 -2.19 47.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.264 0 O-C-N 119.978 -1.701 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.047 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.16 150.4 16.84 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.7 t -62.72 129.37 92.89 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.25 -20.4 32.58 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.0 1.8 . . . . 0.0 112.416 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.89 129.3 34.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.03 -46.1 97.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.305 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -108.11 110.0 62.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.284 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.27 -22.84 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.94 1.76 . . . . 0.0 112.909 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.56 -21.12 61.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.575 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.4 mt -100.0 -2.18 35.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.101 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m -129.07 67.43 78.38 Favored Pre-proline 0 C--O 1.231 0.112 0 CA-C-O 121.224 0.535 . . . . 0.0 110.583 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.95 -21.94 36.58 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 123.198 2.599 . . . . 0.0 111.777 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -78.16 0.99 22.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.561 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.451 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.5 mm -107.56 119.98 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.24 -32.03 73.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.9 t -63.83 -43.41 96.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.33 -31.64 58.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 O-C-N 120.042 -1.661 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.35 43.58 96.65 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.4 t -53.81 129.68 56.04 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.972 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.24 -23.07 33.59 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.276 1.984 . . . . 0.0 112.599 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.13 128.55 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.67 -45.4 98.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -107.88 108.03 60.95 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.904 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.3 -22.15 53.47 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.275 1.983 . . . . 0.0 112.884 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.8 -19.8 61.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.428 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -100.15 -3.37 31.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -129.61 67.95 79.8 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 121.095 0.474 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.18 -20.42 37.61 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 123.234 2.623 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -80.48 2.01 27.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.514 HG21 ' SG ' ' A' ' 3' ' ' CYS . 37.8 mm -108.6 114.56 47.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.74 -31.82 69.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.896 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -64.4 -38.11 89.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.485 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 m -82.87 -29.31 29.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.509 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.29 0 O-C-N 120.123 -1.61 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.77 48.57 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 14' ' ' ILE . 45.9 t -62.51 129.55 92.71 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.976 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -20.33 34.38 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.418 2.079 . . . . 0.0 112.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.4 126.89 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -45.13 99.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.23 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -106.3 108.91 62.64 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.935 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.37 -22.46 45.68 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.423 2.082 . . . . 0.0 112.568 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.24 -20.49 61.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.777 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.7 -5.34 28.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.144 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -128.19 67.45 74.89 Favored Pre-proline 0 C--N 1.333 -0.131 0 CA-C-O 121.315 0.578 . . . . 0.0 110.257 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.64 -18.99 37.26 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 123.514 2.809 . . . . 0.0 112.05 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -82.3 4.26 24.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.294 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.418 HG21 ' SG ' ' A' ' 3' ' ' CYS . 40.3 mm -109.11 120.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.876 0.37 . . . . 0.0 110.022 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -64.1 -32.49 74.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -64.89 -39.61 93.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.37 -14.69 54.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.286 0 O-C-N 119.914 -1.741 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.11 158.99 53.82 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.0 t -63.94 129.49 93.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.807 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.22 -21.66 31.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.897 1.731 . . . . 0.0 112.396 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -81.43 129.21 34.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.325 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.41 -45.2 99.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.252 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -107.5 109.9 62.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.243 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.96 -22.49 41.98 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.932 1.754 . . . . 0.0 112.514 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -71.11 -20.75 62.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.564 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.9 mt -99.53 -4.64 30.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.999 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.33 67.26 78.47 Favored Pre-proline 0 C--O 1.232 0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.495 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.35 -21.96 34.63 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 123.19 2.593 . . . . 0.0 111.928 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -78.65 1.88 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.522 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 3' ' ' CYS . 43.1 mm -107.07 121.61 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -64.12 -32.65 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.3 m -64.96 -40.0 94.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 m -81.36 -3.3 52.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 O-C-N 119.983 -1.698 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.26 -179.05 48.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 14' ' ' ILE . 46.1 t -65.29 129.78 94.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.844 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.53 -22.67 28.22 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.013 1.809 . . . . 0.0 111.968 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 m -81.03 127.27 32.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.309 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.83 -45.07 99.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.913 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -106.91 110.76 63.79 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.079 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.83 -20.61 39.24 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.024 1.816 . . . . 0.0 112.48 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -72.39 -19.27 61.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.631 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.25 -4.01 27.92 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.175 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -129.42 67.37 78.74 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.145 0.498 . . . . 0.0 110.643 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.43 -20.31 36.53 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.129 2.553 . . . . 0.0 112.039 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -80.57 3.65 21.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.318 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 ' SG ' ' A' ' 3' ' ' CYS . 46.3 mm -108.88 121.63 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -64.89 -31.89 73.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.966 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.49 -39.86 92.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.028 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.26 -27.43 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.458 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 120.192 -1.567 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.91 172.2 46.19 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' SG ' HG21 ' A' ' 14' ' ' ILE . 44.7 t -64.64 129.28 94.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.636 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 -24.7 27.07 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.14 1.894 . . . . 0.0 112.112 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.38 128.42 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.66 -45.56 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.43 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -108.28 110.1 61.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 -22.63 47.18 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.14 1.893 . . . . 0.0 112.553 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.51 -20.02 61.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.26 -3.54 31.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.022 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 95.0 m -129.49 68.59 80.55 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.033 0.444 . . . . 0.0 110.669 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 -22.04 38.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.122 2.548 . . . . 0.0 112.119 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -79.29 3.13 18.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.5 mm -109.59 114.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 110.291 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.6 -31.41 70.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.66 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -64.38 -37.74 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.454 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m -85.33 -11.82 53.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 O-C-N 120.026 -1.671 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.39 178.56 48.43 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.6 t -61.68 129.64 91.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.711 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.83 -21.4 33.24 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.017 1.811 . . . . 0.0 112.542 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -82.88 129.44 35.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.294 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.59 -45.23 99.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.139 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -107.72 110.23 62.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.302 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.27 -21.82 47.29 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.905 1.736 . . . . 0.0 112.524 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.33 -20.62 61.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.341 . . . . 0.0 110.743 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.87 -3.77 31.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.199 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 88.3 m -129.48 67.34 78.78 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 121.226 0.536 . . . . 0.0 110.517 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.56 -20.96 35.1 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 123.313 2.675 . . . . 0.0 111.754 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -78.73 1.69 22.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.197 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 ' SG ' ' A' ' 3' ' ' CYS . 41.9 mm -107.5 120.95 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -64.52 -32.48 74.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.57 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.6 t -64.04 -43.52 95.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.35 -28.5 53.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.481 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.321 0 O-C-N 119.944 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.75 -169.23 53.15 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.3 t -60.85 129.64 90.25 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.569 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.79 -22.41 36.9 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.618 2.212 . . . . 0.0 112.398 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.6 129.06 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -45.41 98.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.068 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -107.82 112.09 62.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.099 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 -22.03 38.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.439 2.093 . . . . 0.0 112.557 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -72.78 -17.86 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.638 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.58 -6.25 23.02 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.684 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.6 m -128.24 68.02 76.05 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-O 121.095 0.474 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -19.77 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.285 2.656 . . . . 0.0 112.074 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -79.57 2.64 21.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.883 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -108.91 112.99 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -57.97 -32.86 68.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.768 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.974 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -80.22 -20.33 44.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.726 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 120.051 -1.656 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.75 -178.31 51.26 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -64.41 130.25 94.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.911 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.01 -22.52 26.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.837 1.691 . . . . 0.0 112.355 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 m -78.08 128.44 33.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.391 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.85 -45.35 99.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.24 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -107.16 108.22 61.6 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.39 -21.83 46.51 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.837 1.692 . . . . 0.0 112.516 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.53 -21.28 62.75 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.2 mt -99.07 -2.99 35.76 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.7 m -129.67 68.3 80.34 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 121.363 0.601 . . . . 0.0 110.581 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.76 -22.28 32.31 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.003 2.469 . . . . 0.0 111.881 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -78.49 -0.29 28.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.599 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.488 HG21 ' SG ' ' A' ' 3' ' ' CYS . 42.4 mm -105.36 121.14 57.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.04 -32.52 74.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.031 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.3 m -79.62 -24.04 42.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.517 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 120.052 -1.655 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.035 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.66 -178.93 52.71 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' A' ' 14' ' ' ILE . 37.6 t -62.23 129.73 92.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.028 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.1 -23.92 60.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.14 1.893 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 m -84.5 128.26 34.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.328 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.33 -44.54 99.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.984 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -106.79 108.83 62.58 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.024 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.57 -21.77 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.021 1.814 . . . . 0.0 112.926 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -18.56 62.96 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.692 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.25 -5.14 25.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.331 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.28 67.3 78.45 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-O 121.239 0.542 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.47 -21.31 40.55 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.24 2.627 . . . . 0.0 112.309 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -80.58 3.71 20.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.58 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.417 HG21 ' SG ' ' A' ' 3' ' ' CYS . 27.1 mm -108.76 120.8 60.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.979 0.419 . . . . 0.0 109.891 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -63.15 -31.72 72.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -65.09 -39.69 93.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.01 -23.04 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.293 0 O-C-N 120.191 -1.568 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.41 -168.05 53.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 14' ' ' ILE . 41.9 t -62.86 129.51 93.2 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.784 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.86 -22.12 43.13 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.048 1.832 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -83.31 129.07 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.17 -45.26 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.06 109.28 61.93 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.87 -23.53 47.48 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.023 1.815 . . . . 0.0 112.506 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -70.35 -20.97 62.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.402 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.2 mt -98.92 -6.1 29.5 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.8 m -129.05 67.28 78.13 Favored Pre-proline 0 C--N 1.335 -0.032 0 CA-C-O 121.351 0.596 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.88 -20.88 33.68 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.17 2.58 . . . . 0.0 111.825 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -79.19 0.31 28.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.296 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 3' ' ' CYS . 38.2 mm -105.36 113.85 43.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -57.38 -32.28 66.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.2 t -64.87 -40.23 94.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.791 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.44 -30.32 37.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.31 0 O-C-N 120.147 -1.596 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.8 -171.46 43.01 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG21 ' A' ' 14' ' ' ILE . 38.3 t -62.86 129.42 93.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -20.87 33.95 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.284 1.99 . . . . 0.0 112.411 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.0 m -82.67 128.21 34.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.241 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.21 -45.4 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.914 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.97 109.9 62.14 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.937 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.54 -21.98 52.01 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.211 1.941 . . . . 0.0 112.788 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -71.1 -19.48 62.45 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.416 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.15 -4.77 28.96 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 99.5 m -129.23 66.95 77.83 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 121.177 0.513 . . . . 0.0 110.331 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.2 -20.53 37.33 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 123.317 2.678 . . . . 0.0 111.874 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -81.65 5.75 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.331 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.401 HG21 ' SG ' ' A' ' 3' ' ' CYS . 31.7 mm -110.62 121.09 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -63.57 -32.21 73.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.576 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.4 m -64.59 -39.95 94.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.37 -13.29 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.466 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.316 0 O-C-N 120.129 -1.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.3 178.92 48.68 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 14' ' ' ILE . 49.8 t -65.51 129.73 94.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.906 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.37 -20.3 21.15 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.987 2.458 . . . . 0.0 112.263 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 131.61 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.8 -43.95 98.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.37 . . . . 0.0 110.472 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.434 ' HB2' HD12 ' A' ' 10' ' ' LEU . 86.8 m95 -109.64 112.17 58.75 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.195 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.99 -22.17 31.39 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.606 2.204 . . . . 0.0 111.838 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.33 -22.14 60.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.751 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 7' ' ' TRP . 82.5 mt -96.71 -14.93 21.7 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.261 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.1 m -123.3 65.2 29.69 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 121.419 0.628 . . . . 0.0 110.214 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -15.26 33.43 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.366 2.711 . . . . 0.0 112.671 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -85.13 4.01 36.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.808 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 17' ' ' CYS . 44.2 mm -106.56 116.09 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.692 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -58.84 -32.12 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.76 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 m -66.51 -38.51 87.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.617 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 14' ' ' ILE . 1.6 m -82.18 -12.76 57.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 O-C-N 119.993 -1.692 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_